Concepedia
Statistics
Publications
7
Citations
1.1K
H-Index
Active since
2006
Affiliations
University of California, San Francisco(Current)
Neurological Surgery
UCSF Helen Diller Family Comprehensive Cancer Center
The Ohio State University
Michael De Lay is an author at University of California, San Francisco specializing in molecular oncology, oncology, and medicine.
Publications per year
2006–2017
MicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
Jakub Godlewski, Michal O. Nowicki, Agnieszka Bronisz et al. · Molecular Cell · 2010 · 425 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +14
Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
Arman Jahangiri, Michael De Lay, Liane M. Miller et al. · Clinical Cancer Research · 2013 · 204 citations · Full text
Medicine, Oncology, Pharmacology +17
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
Brandyn Castro, Patrick M. Flanigan, Arman Jahangiri et al. · Oncogene · 2017 · 141 citations · Full text
Medicine, Cancer Biology, Oncology +17
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia
Amy J. Johnson, David Lucas, Natarajan Muthusamy et al. · Blood · 2006 · 128 citations · Full text
Medicine, Cancer Biology, Oncology +10
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Arman Jahangiri, Alan Nguyen, Ankush Chandra et al. · Proceedings of the National Academy of Sciences · 2017 · 81 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 7